🇺🇸 FDA
Patent

US 9752118

Method of directed differentiation producing corneal endothelial cells from neural crest stem cells by PDGFB and DKK2, compositions thereof, and uses thereof

granted A61KA61K35/30A61K45/06

Quick answer

US patent 9752118 (Method of directed differentiation producing corneal endothelial cells from neural crest stem cells by PDGFB and DKK2, compositions thereof, and uses thereof) held by Astellas Institute for Regenerative Medicine expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/30, A61K45/06, A61K9/0048